SN-38-loaded electrospun composite nanofiber scaffolds for the treatment of human glioma cells in vitro

Xiaodong ZHU,Tongliang XIA,Qingyu YAO,Haoyuan LI,Benlin WANG,Shilei NI,Jiangang WANG,Xingang LI,Wandong SU
DOI: https://doi.org/10.6040/j.issn.1671-7554.0.2014.826
2015-01-01
Abstract:Objective To establisht an effectively controlled release system which was based on 7-ethyl-10-hydroxyl camptothecin (SN-38)-loaded electrospun composite nanofiber with poly (ε-caprolactone)(PCL)/poly (D,L-lac-tide)(PDLLA)and to evaluate its antitumor activity against U-251 glioma cells in vitro.Methods SN-38-loaded PCL/PDLLA fibers were manufactured by electrospinning.The physical status of SN-38 within the polymeric fibers was investigated by different scanning calorimetry (DSC)and fourier transform infrared (FT-IR).The static wettability of the membrane was measured by contact angle analyzer.The release speeds of two samples were determined,and their cytotoxicity against U-251 glioma cells was assessed in vitro.Results Uniform and smooth SN-38-loaded PCL/PDL-LA fibers were obtained.Cell toxicity test results showed that the SN-38-loaded PCL/PDLLA fibers could continuously inhibit the U-251 glioma cells.Due to different drug-loading rates,different membranes showed various release time. The antitumor activity of the 2 wt.% SN-38-loaded PCL/PDLLA nanofiber meshes were controlled and sustained. Conclusions Using SN-38-loaded composite nanofiber of PCL/PDLLA as a sustained delivery system is feasible. While the drug-loading rate is augmented,the release time of drug within the fibers will be increased accordingly.
What problem does this paper attempt to address?